1. Zanni, MV, Schouten, J, Grinspoon, SK, et al. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol 2014; 11(12): 728–741.
Google Scholar | Crossref | Medline | ISI2. Triant, VA, Lee, H, Hadigan, C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92(7): 2506–2512.
Google Scholar | Crossref | Medline | ISI3. Ryom, L, Lundgren, JD, Ross, M, et al. Renal impairment and cardiovascular disease in HIV-positive individuals: The D:A:D study. J Infect Dis 2016; 214(8): 1212–1220.
Google Scholar | Crossref | Medline4. Rasmussen, LD, Helleberg, M, May, MT, et al. Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking. Clin Infect Dis 2015; 60(9): 1415–1423.
Google Scholar | Medline5. Boccara, F, Mary-Krause, M, Teiger, E, et al. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J 2011; 32(1): 41–50.
Google Scholar | Crossref | Medline6. Lang, S, Mary-Krause, M, Cotte, L, et al. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med 2010; 170(14): 1228–1238.
Google Scholar | Crossref | Medline7. Friis-Møller, N, Sabin, CA, Weber, R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349(21): 1993–2003.
Google Scholar | Crossref | Medline | ISI8. Friis-Moller, N, Friis-Møller, N, Reiss, P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356(17): 1723–1735.
Google Scholar | Crossref | Medline | ISI9. Zanni, MV, Grinspoon, SK. HIV-specific immune dysregulation and atherosclerosis. Curr HIV/AIDS Rep 2012; 9(3): 200–205.
Google Scholar | Crossref | Medline10. Hunt, PW . HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012; 9(2): 139–147.
Google Scholar | Crossref | Medline11. Beires, MT, Silva-Pinto, A, Santos, AC, et al. Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study. BMC Infect Dis 2018; 18(1): 32.
Google Scholar | Crossref | Medline12. Kelly, SG, Plankey, M, Post, WS, et al. Associations between tobacco, alcohol, and drug use with coronary artery plaque among HIV-infected and uninfected men in the multicenter AIDS cohort study. PLoS One 2016; 11(1): e0147822.
Google Scholar | Crossref | Medline13. Howell, LL, Carroll, FI, Votaw, JR, et al. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 2007; 320(2): 757–765.
Google Scholar | Crossref | Medline14. Vongpatanasin, W, Mansour, Y, Chavoshan, B, et al. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 1999; 100(5): 497–502.
Google Scholar | Crossref | Medline | ISI15. Schwartz, BG, Rezkalla, S, Kloner, RA. Cardiovascular effects of cocaine. Circulation 2010; 122(24): 2558–2569.
Google Scholar | Crossref | Medline16. Maraj, S, Figueredo, VM, Lynn Morris, D. Cocaine and the heart. Clin Cardiol 2010; 33(5): 264–269.
Google Scholar | Crossref | Medline17. Lange, RA, Hillis, LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345(5): 351–358.
Google Scholar | Crossref | Medline18. Feldman, JA, Fish, SS, Beshansky, JR, et al. Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med 2000; 36(5): 469–476.
Google Scholar | Crossref | Medline19. Weber, JE, Chudnofsky, CR, Boczar, M, et al. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med 2000; 7(8): 873–877.
Google Scholar | Crossref | Medline20. Kanani, PM, Guse, PA, Smith, WM, et al. Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166. J Cardiovasc Pharmacol 1998; 32(1): 42–48.
Google Scholar | Crossref | Medline21. Henning, RJ, Li, Y. Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanisms. J Cardiovasc Pharmacol Ther 2003; 8(2): 149–160.
Google Scholar | SAGE Journals22. Frustaci, A, Russo, MA, Morgante, E, et al. Oxidative myocardial damage in human cocaine-related cardiomyopathy. Eur J Heart Fail 2015; 17(3): 283–290.
Google Scholar | Crossref | Medline23. Brickner, ME, Willard, JE, Eichhorn, EJ, et al. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation 1991; 84(3): 1130–1135.
Google Scholar | Crossref | Medline24. Crane, HM, Paramsothy, P, Drozd, DR, et al. Types of myocardial infarction among human immunodeficiency virus-infected individuals in the United States. JAMA Cardiol 2017; 2(3): 260–267.
Google Scholar | Crossref | Medline25. Lai, S, Lima, JA, Lai, H, et al. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med 2005; 165(6): 690–695.
Google Scholar | Crossref | Medline26. Lai, H, Moore, R, Celentano, DD, et al. HIV infection itself may not be associated with subclinical coronary artery disease among African Americans without cardiovascular symptoms. J Am Heart Assoc 2016; 5(3): e002529.
Google Scholar | Crossref | Medline27. Fox, HC, D'Sa, C, Kimmerling, A, et al. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol 2012; 27(2): 156–166.
Google Scholar | Crossref | Medline28. Miller, GE, Blackwell, E. Turning up the heat. Curr Dir Psychol Sci 2006; 15(6): 269–272.
Google Scholar | SAGE Journals | ISI29. Nezu, T, Hosomi, N, Aoki, S, et al. Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb 2016; 23(1): 18–31.
Google Scholar | Crossref | Medline30. Grunfeld, C, Delaney, JA, Wanke, C, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. Aids 2009; 23(14): 1841–1849.
Google Scholar | Crossref | Medline31. Kalichman, SC, DiMarco, M, Austin, J, et al. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med 2003; 26(4): 315–332.
Google Scholar | Crossref | Medline | ISI32. Sinha, R . Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 2008; 1141: 105–130.
Google Scholar | Crossref | Medline | ISI33. Ben-Shlomo, Y, Kuh, D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Oxford, England: Oxford University Press, 2002.
Google Scholar34. Zdrenghea, D, Guşetu, G, Zdrenghea, M, et al. CV RISK - a new relative cardiovascular risk score. Med Hypotheses 2019; 132: 109362.
Google Scholar | Crossref | Medline35. Boglioni, FV, Metra, M, Locati, M, et al. Role of inflammation mediators in the pathogenesis of heart failure. Ital Heart J Suppl 2001; 2(6): 628–633.
Google Scholar | Medline36. Bielecka-Dabrowa, A, Wierzbicka, M, Goch, JH. Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target. Wiad Lek 2007; 60(9–10): 433–438.
Google Scholar | Medline37. Jones, DL, Rodriguez, VJ, Alcaide, ML, et al. Subclinical atherosclerosis among young and middle-aged adults using carotid intima-media thickness measurements. South Med J 2017; 110(11): 733–737.
Google Scholar | Crossref | Medline38. Alcaide, ML, Rodriguez, VJ, Abbamonte, JM, et al. HIV and carotid atherosclerosis: a mediational model. AIDS Care 2019: 1–5.
Google Scholar39. Sikkeland, LI, Dahl, CP, Ueland, T, et al. Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure. PloS One 2012; 7(5): e36815.
Google Scholar | Crossref | Medline | ISI40. von Lueder, TG, Kjekshus, H, Edvardsen, T, et al. Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1. Cardiovasc Res 2004; 63(1): 41–50.
Google Scholar | Crossref | Medline41. Rundek, T, Arif, H, Boden-Albala, B, et al. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008; 70(14): 1200–1207.
Google Scholar | Crossref | Medline | ISI42. Intelligence in Medical Technologies . M'Ath. Paris, France: IMT.
Google Scholar43. Radloff, LS . The CES-D scale. Appl Psychol Meas 1977; 1(3): 385–401.
Google Scholar | SAGE Journals44. IPAQ . The international physical activity questionnaire. http://www.ipaq.ki.se/
Google Scholar45. Craig, CL, Marshall, AL, Sjöström, M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35(8): 1381–1395.
Google Scholar | Crossref | Medline | ISI46. Gans, KM, Ross, E, Barner, CW, et al. REAP and WAVE: new tools to rapidly assess/discuss nutrition with patients. J Nutr 2003; 133(2): 556S–62S.
Google Scholar | Crossref | Medline47. First, MB, Spitzer, RL, Gibbon, M, et al. User’s guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version, 1997.
Google Scholar48. Segal, DL, Hersen, M, Van Hasselt, VB. Reliability of the structured clinical interview for DSM-III-R: an evaluative review. Compr Psychiatry 1994; 35(4): 316–327.
Google Scholar | Crossref | Medline49. Ness‐Abramof, R, Apovian, CM. Waist circumference measurement in clinical practice. Nutr Clin Pract 2008; 23(4): 397–404.
Google Scholar | Crossref | Medline50. Kones, R . Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease–a perspective. Drug Des Devel Ther 2010; 4: 383–413.
Google Scholar | Crossref | Medline | ISI51. Koenig, W . High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol 2013; 168(6): 5126–5134.
Google Scholar | Crossref | Medline | ISI